Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles

Abstract Background Currently, the Bilayer tablets, Tablet in tablet and Inlay tablets composed of Glimepiride (GMP) and Pioglitazone (PGH) as immediate release part, and Metformin (MFH) as sustained-release part are available for the treatment of type II diabetes mellitus (T2DM). In these products,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vandana Dhanorkar, Pranav Shah
Formato:	article
Lenguaje:	EN
Publicado:	SpringerOpen 2021
Materias:	Metformin hydrochloride Glimepiride Pioglitazone hydrochloride Pellets Design of experiment Pharmacokinetics Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441
Acceso en línea:	https://doaj.org/article/077c1745a0ec4d43901d732766f6e1d7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:077c1745a0ec4d43901d732766f6e1d7
record_format	dspace
spelling	oai:doaj.org-article:077c1745a0ec4d43901d732766f6e1d72021-11-08T11:04:39ZDevelopment and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles10.1186/s43094-021-00374-52314-7253https://doaj.org/article/077c1745a0ec4d43901d732766f6e1d72021-11-01T00:00:00Zhttps://doi.org/10.1186/s43094-021-00374-5https://doaj.org/toc/2314-7253Abstract Background Currently, the Bilayer tablets, Tablet in tablet and Inlay tablets composed of Glimepiride (GMP) and Pioglitazone (PGH) as immediate release part, and Metformin (MFH) as sustained-release part are available for the treatment of type II diabetes mellitus (T2DM). In these products, there is a possibility of the incomplete release of immediate release part (GMP and PGH) due to their entrapment into high viscosity gel barrier of MFH sustained-release part when drug product comes in contact with media. Therefore, the present study was aimed to deliver the above combination drugs in the form of hard gelatin capsules (as unit dosage form) containing MFH sustained-release (MFH-SR) pellets and immediate release pellets of PGH and GMP (PG-IR). Results The MFH-SR and GP-IR pellets, prepared by extrusion and spheronization technique, were optimized based on the drug content and % cumulative drug release. The MFH-SR pellets formulation (batch A6) has shown maximum drug content, and sustained-release of MFH similar to marketed glucophage tablet while, the GP-IR pellets formulation (batch B5) has displayed maximum drug contents and immediate release of GMP and PGH; thus, these batches were considered for further characterizations. The optimized MFH-SR and GP-IR formulations have shown particle sizes of 0.23 ± 0.0010 mm and 0.35 ± 0.0018 mm, respectively. Besides, the formulations exhibited good micromeritics properties. The in vivo pharmacokinetic study in rabbits has demonstrated comparable bioavailability of the drugs from pellets and the marketed formulations following oral administration. Further, the pellets were found to be stable for 6 months at 40 ± 2 °C/75% ± 5%RH. Conclusions The study results revealed that the multiparticulate systems with varied release profiles could be a promising approach to overcome drug release issues associated with the unit dosage forms.Vandana DhanorkarPranav ShahSpringerOpenarticleMetformin hydrochlorideGlimepiridePioglitazone hydrochloridePelletsDesign of experimentPharmacokineticsTherapeutics. PharmacologyRM1-950Pharmacy and materia medicaRS1-441ENFuture Journal of Pharmaceutical Sciences, Vol 7, Iss 1, Pp 1-12 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Metformin hydrochloride Glimepiride Pioglitazone hydrochloride Pellets Design of experiment Pharmacokinetics Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441
spellingShingle	Metformin hydrochloride Glimepiride Pioglitazone hydrochloride Pellets Design of experiment Pharmacokinetics Therapeutics. Pharmacology RM1-950 Pharmacy and materia medica RS1-441 Vandana Dhanorkar Pranav Shah Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
description	Abstract Background Currently, the Bilayer tablets, Tablet in tablet and Inlay tablets composed of Glimepiride (GMP) and Pioglitazone (PGH) as immediate release part, and Metformin (MFH) as sustained-release part are available for the treatment of type II diabetes mellitus (T2DM). In these products, there is a possibility of the incomplete release of immediate release part (GMP and PGH) due to their entrapment into high viscosity gel barrier of MFH sustained-release part when drug product comes in contact with media. Therefore, the present study was aimed to deliver the above combination drugs in the form of hard gelatin capsules (as unit dosage form) containing MFH sustained-release (MFH-SR) pellets and immediate release pellets of PGH and GMP (PG-IR). Results The MFH-SR and GP-IR pellets, prepared by extrusion and spheronization technique, were optimized based on the drug content and % cumulative drug release. The MFH-SR pellets formulation (batch A6) has shown maximum drug content, and sustained-release of MFH similar to marketed glucophage tablet while, the GP-IR pellets formulation (batch B5) has displayed maximum drug contents and immediate release of GMP and PGH; thus, these batches were considered for further characterizations. The optimized MFH-SR and GP-IR formulations have shown particle sizes of 0.23 ± 0.0010 mm and 0.35 ± 0.0018 mm, respectively. Besides, the formulations exhibited good micromeritics properties. The in vivo pharmacokinetic study in rabbits has demonstrated comparable bioavailability of the drugs from pellets and the marketed formulations following oral administration. Further, the pellets were found to be stable for 6 months at 40 ± 2 °C/75% ± 5%RH. Conclusions The study results revealed that the multiparticulate systems with varied release profiles could be a promising approach to overcome drug release issues associated with the unit dosage forms.
format	article
author	Vandana Dhanorkar Pranav Shah
author_facet	Vandana Dhanorkar Pranav Shah
author_sort	Vandana Dhanorkar
title	Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
title_short	Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
title_full	Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
title_fullStr	Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
title_full_unstemmed	Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
title_sort	development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles
publisher	SpringerOpen
publishDate	2021
url	https://doaj.org/article/077c1745a0ec4d43901d732766f6e1d7
work_keys_str_mv	AT vandanadhanorkar developmentandcharacterizationofmultiparticulatesystemasanalternativetounitdosageformscontainingdrugswithdiversereleaseprofiles AT pranavshah developmentandcharacterizationofmultiparticulatesystemasanalternativetounitdosageformscontainingdrugswithdiversereleaseprofiles
_version_	1718442302976819200

Development and characterization of multiparticulate system as an alternative to unit dosage forms containing drugs with diverse release profiles

Ejemplares similares